MediPharm Labs Corp.
MEDIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $10 | $8 | $12 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $8 | $8 | $8 |
| Inventory | $8 | $9 | $11 | $9 |
| Other Curr. Assets | $2 | $2 | $5 | $5 |
| Total Curr. Assets | $28 | $30 | $32 | $33 |
| Property Plant & Equip (Net) | $18 | $18 | $19 | $19 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $19 | $20 | $20 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $47 | $49 | $52 | $54 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $4 |
| Short-Term Debt | $0 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $1 | $1 |
| Other Curr. Liab. | $3 | $4 | $3 | $5 |
| Total Curr. Liab. | $9 | $9 | $9 | $10 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $9 | $9 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $202 | $202 | $201 | $201 |
| Retained Earnings | -$189 | -$186 | -$188 | -$187 |
| AOCI | -$0 | $25 | $30 | $29 |
| Other Equity | $25 | $0 | $0 | $0 |
| Total Equity | $38 | $40 | $43 | $43 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $47 | $49 | $52 | $54 |
| Net Debt | -$10 | -$10 | -$8 | -$11 |